Sweden's Zinzino Q4 revenue up 45%, raises dividend 50%

Zinzino AB

25/02/2026 07:09

Overview

Sweden health tech firm's Q4 revenue rose 45% yr/yr

EBITDA margin improved due to stronger gross profit and synergies

Company increased dividend by 50% to SEK 6 per share

Outlook

Company did not provide specific guidance for future quarters or years

Result Drivers

ACQUISITIONS AND SYNERGIES - Improved EBITDA margin due to stronger gross profit and increased synergies from Zurvita acquisition

EXPANSION STRATEGY - Acquired 35% of Xion International Group and assets of Sanki to enhance supply chain and distribution in Americas

NEW PRODUCT LAUNCH - Introduced Gut Health Test, contributing to growth strategy

Company press release: ID:nWkr9YZxM3

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Gross Margin
35.80%
Q4 EBITDA
SEK 175.20 mln
Q4 EBITDA Margin
16.90%
Q4 Gross Profit
SEK 370.30 mln


Analyst Coverage

Wall Street's median 12-month price target for Zinzino AB is SEK221.00, about 73.7% above its February 24 closing price of SEK127.20

The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 14 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)